Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.
The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
Regional body fat distribution has an important influence on metabolic and cardiovascular risk factors. Increased abdominal (visceral) fat accumulation is a risk factor for coronary artery disease (CAD), dyslipidemia, hypertension, stroke, and type 2 diabetes. The recent emphasis on treatment of the dyslipidemia of the metabolic syndrome (hypertriglyceridemia, reduced high-density lipoprotein, and increased small, dense low-density lipoprotein particle number) has compelled practitioners to consider lipid-lowering therapy in a greater number of their patients, as one in two individuals over age 50 has the metabolic syndrome. Individuals with the metabolic syndrome typically have normal low-density lipoprotein cholesterol levels, and current lipid-lowering guidelines may underestimate their cardiovascular risk. Two subgroups of patients with the metabolic syndrome are at particularly high risk for premature CAD. One, individuals with type 2 diabetes, accounts for 20–30% of early cardiovascular disease. The second, familial combined hyperlipidemia, accounts for an additional 10–20% of premature CAD. Familial combined hyperlipidemia is characterized by the metabolic syndrome in addition to a disproportionate elevation of apolipoprotein B levels. The measurement of fasting glucose and apolipoprotein B, in addition to the fasting lipid profile, can help to estimate CAD risk in patients with the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In patients with the metabolic syndrome, treated type 2 diabetes mellitus, or FCHL, the number of small, dense LDL and HDL particles and the apoB levels are increased (25,26).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [26]
In the citing paper
“Type 2 diabetes mellitus, polycystic ovary syndrome, and FCHL may account for at least 40 -50% of premature coronary artery disease in some populations with metabolic syndrome, and they need to be considered in assessing the risk of CVD in patients who have the metabolic syndrome (26).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [26]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074
Larsson, B., Svärdsudd, K., Welin, L., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1984) · BMJ · doi:10.1136/bmj.288.6428.1401 · Cited by 1,934
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Lapidus, L., Bengtsson, C., Larsson, B., Pennert, K., Rybo, E., & Sjöström, L. (1984) · BMJ · doi:10.1136/bmj.289.6454.1257 · Cited by 1,660
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,443
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
Walldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,229
Stampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N., Fabunmi, R. P., Grady, D., Haan, C. K., Hayes, S. N., Judelson, D. R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000114834.85476.81 · Cited by 917
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843
Familial lipoprotein disorders in patients with premature coronary artery disease.
Genest, J. J., Martin-Munley, S. S., McNamara, J. R., Ordovas, J. M., Jenner, J., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2025 · Cited by 596
Sex differences in the relation of visceral adipose tissue accumulation to total body fatness
Lemieux, S., Prud'homme, D., Bouchard, C., Tremblay, A., & Després, J. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.4.463 · Cited by 561
Chait, A., Brazg, R. L., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554
Grundy, S. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.14.1568 · Cited by 551
Haffner, S. M., Ralph, D., Saad, M. F., Rewers, M., Mykkänen, L., Selby, J., Howard, G., Savage, P. J., Hamman, R. F., Wegenknecht, L. E., et al. (1996) · Diabetes · doi:10.2337/diab.45.6.742 · Cited by 536
Girman, C. J., Rhodes, T., Mercuri, M., Pyörälä, K., Kjekshus, J., Pedersen, T. R., Beere, P. A., Gotto, A. M., & Clearfield, M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.028 · Cited by 526
Elam, M. B., Hunninghake, D. B., Davis, K. B., Garg, R., Johnson, C., Egan, D., Kostis, J. B., Sheps, D. S., Brinton, E. A., & for the ADMIT Investigators (2000) · JAMA · doi:10.1001/jama.284.10.1263 · Cited by 517
Low density lipoprotein particle size and coronary artery disease.
Campos, H., Genest, J. J., Blijlevens, E., McNamara, J. R., Jenner, J. L., Ordovas, J. M., Wilson, P. W., & Schaefer, E. J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.2.187 · Cited by 509
Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476
Meigs, J. B., Wilson, P. W. F., Nathan, D. M., D’Agostino, R. B., Williams, K., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2160 · Cited by 464
Age Changes in Body Composition Revealed by Computed Tomography
Borkan, G. A., Hults, D. E., Gerzof, S. G., Robbins, A. H., & Silbert, C. K. (1983) · Journal of Gerontology · doi:10.1093/geronj/38.6.673 · Cited by 460
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
Sniderman, A., Furberg, C., Keech, A., van Lennep, J. R., Frohlich, J., Jungner, I., & Walldius, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12663-3 · Cited by 457
Dyslipidemia Management in Adults With Diabetes
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s68 · Cited by 445
Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
Haarbo, J., Marslew, U., Gotfredsen, A., & Christiansen, C. (1991) · Metabolism · doi:10.1016/0026-0495(91)90037-w · Cited by 441
McNamara, J. R., Campos, H., Ordovas, J. M., Peterson, J., Wilson, P. W., & Schaefer, E. J. (1987) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.7.5.483 · Cited by 383
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 336
Eschwège, É., Richard, J. L., Thibult, N., Ducimetière, P., Warnet, J., Claude, J., & Rosselin, G. (1985) · PubMed · Cited by 311
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
Brunzell, J. D., Albers, J. J., Chait, A., Grundy, S. M., Groszek, E., & McDonald, G. B. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38008-1 · Cited by 305
Self-citationMyocardial infarction in the familial forms of hypertriglyceridemia
Brunzell, J. D., Schrott, H. G., Motulsky, A. G., & Bierman, E. L. (1976) · Metabolism · doi:10.1016/0026-0495(76)90089-5 · Cited by 303
Self-citationKissebah, A. H., Alfarsi, S., & Adams, P. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90064-0 · Cited by 295
FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASE
Nikkilä, E., & Aro, A. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91598-5 · Cited by 292
Thrombogenic Factors and Recurrent Coronary Events
Moss, A. J., Goldstein, R. E., Marder, V. J., Sparks, C. E., Oakes, D., Greenberg, H., Weiss, H. J., Zareba, W., Brown, M. W., Liang, C.-S., et al. (1999) · Circulation · doi:10.1161/01.cir.99.19.2517 · Cited by 280
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
CHAIT, A., ALBERS, J. J., & BRUNZELL, J. D. (1980) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1980.tb00004.x · Cited by 277
Self-citationDucimetière, P., Richard, J. L., & Cambien, F. (1986) · PubMed · Cited by 271
Lipoprotein predictors of the severity of coronary artery disease in men and women.
Reardon, M. F., Nestel, P. J., Craig, I. H., & Harper, R. W. (1985) · Circulation · doi:10.1161/01.cir.71.5.881 · Cited by 266
Zambon, A., Hokanson, J. E., Brown, B. G., & Brunzell, J. D. (1999) · Circulation · doi:10.1161/01.cir.99.15.1959 · Cited by 263
Self-citationAustin, M. A., McKnight, B., Edwards, K. L., Bradley, C. M., McNeely, M. J., Psaty, B. M., Brunzell, J. D., & Motulsky, A. G. (2000) · Circulation · doi:10.1161/01.cir.101.24.2777 · Cited by 255
Self-citationDeitch, R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91664-0 · Cited by 249
Prevalence of risk factors in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90924-a · Cited by 243
Talmud, P. J., Hawe, E., Miller, G. J., & Humphries, S. E. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000035521.22199.c7 · Cited by 233
The role of hepatic lipase in lipoprotein metabolism and atherosclerosis
Santamarina-Fojo, S., Haudenschild, C., & Amar, M. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00005 · Cited by 230
Björnheden, T., Babyi, A., Bondjers, G., & Wiklund, O. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05770-6 · Cited by 230
Prevalence of Risk Factors in Men With Premature Coronary Artery Disease
Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1992) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199203010-00011 · Cited by 217
Hopkins, P. N., Heiss, G., Ellison, R. C., Province, M. A., Pankow, J. S., Eckfeldt, J. H., & Hunt, S. C. (2003) · Circulation · doi:10.1161/01.cir.0000081777.17879.85 · Cited by 207
A PROPOSED GENETIC MARKER FOR CORONARY HEART DISEASE RISK
Austin, King, M., VRANIZAN, K. M., & Krauss, R. M. (1990) · Cited by 194
Tribble, D. L., Rizzo, M., Chait, A., Lewis, D. M., Blanche, P. J., & Krauss, R. M. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00700-2 · Cited by 185
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Bonadonna, R. C., & Muggeo, M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802381 · Cited by 184
Hurt-Camejo, E., Camejo, G., Rosengren, B., Lopez, F., Wiklund, O., & Bondjers, G. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42610-0 · Cited by 162
Bachorik, P. S., Lovejoy, K. L., Carroll, M. D., & Johnson, C. L. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2364 · Cited by 155
Veenkamp (2002) · doi:10.1161/hq0202.104059 · Cited by 152
Tornvall, P., Karpe, F., Carlson, L. A., & Hamsten, A. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90245-x · Cited by 147
Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
Rose, H. G., Kranz, P., Weinstock, M., Juliano, J., & Haft, J. I. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90218-0 · Cited by 132
Carr, M. C., Hokanson, J. E., Zambon, A., Deeb, S. S., Barrett, P. H. R., Purnell, J. Q., & Brunzell, J. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7586 · Cited by 130
Self-citationZhao, X.-Q., Morse, J. S., Dowdy, A. A., Heise, N., DeAngelis, D., Frohlich, J. J., Chait, A., Albers, J. J., & Brown, B. G. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.009 · Cited by 112
The visceral adiposity syndrome in Japanese-American men.
Fujimoto, W., Abbate, S. L., Kahn, S. E., Hokansno, J. E., & Brunzell, J. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00076.x · Cited by 111
Self-citationTreatment for patients with the metabolic syndrome
Ginsberg, H. N. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03386-6 · Cited by 105
Swinkels, D. W., Demacker, P. N. M., Hendriks, J. C. M., & Laar, A. V. '. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.5.604 · Cited by 105
Familial aggregation of abdominal visceral fat level: Results from the Quebec family study
Përusse, L., Després, J., Lemieux, S., Rice, T., Rao, D. C., & Bouchard, C. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90294-2 · Cited by 104
Ayyobi, A. F., McGladdery, S. H., McNeely, M. J., Austin, M. A., Motulsky, A. G., & Brunzell, J. D. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000077220.44620.9b · Cited by 103
Self-citationJarvik, G. P., Brunzell, J. D., Austin, M. A., Krauss, R. M., Motulsky, A. G., & Wijsman, E. M. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1687 · Cited by 92
Self-citationVoors‐Pette, C., & de Bruin, T. W. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00752-8 · Cited by 71
Meyers, C. D., Carr, M. C., Park, S., & Brunzell, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-12-200312160-00009 · Cited by 71
Self-citationBredie, S. J. H., Tack, C. J., Smits, P., & Stalenhoef, A. F. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.17v07.1465 · Cited by 64
Purnell, J. Q., Kahn, S. E., Schwartz, R. S., & Brunzell, J. D. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.567 · Cited by 60
Self-citationKeulen, E. T. P., Kruijshoop, M., Schaper, N. C., Hoeks, A. P. G., & de Bruin, T. W. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104100 · Cited by 59
Fujimoto, W. Y. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90022-j · Cited by 57
Keulen, E. T. P. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01280-2 · Cited by 47
Marsh, J. B. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.nov.363-375 · Cited by 45
Non–High-Density Lipoprotein Cholesterol Level as Potential Risk Predictor and Therapy Target
Grundy, S. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1379 · Cited by 43
Familial combined hyperlipidaemia: 1973-1991.
Cabezas, M. C., de Bruin, T. W. A., & Erkelens, D. W. (1992) · PubMed · Cited by 37
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0034 · Cited by 2,445
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Metadata
- Authors
- Carr, M. C., & Brunzell, J. D.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- ORCID
- Brunzell, John D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 89
- Issue
- 6
- Pages
- 2601-2607
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2163802092
- Cited by
- 493
- References
- 83
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 19 · 2020: 20 · 2019: 17 · 2018: 46 · 2017: 19 · 2016: 18 · 2015: 18 · 2014: 29 · 2013: 27 · 2012: 20
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL030086, HL3-0086, HL 64322, R01HL064322)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 02456)
- National Center for Research Resources (K23RR16067, M01-RR 00037, K23RR016067, M01RR000037)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- abdominal obesity, visceral fat, metabolic syndrome, dyslipidemia, type 2 diabetes, familial combined hyperlipidemia, coronary artery disease risk, apolipoprotein B, lipid-lowering therapy, cardiovascular risk assessment, fasting blood glucose, small dense LDL, HDL cholesterol
- MeSH terms
- Abdomen, Coronary Artery Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemia, Familial Combined, Obesity, Risk Factors, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.